Amphetamine
Amphetamines
Central Nervous System Stimulants
Dextroamphetamine
Methamphetamine
Substance Abuse Detection
N-Methyl-3,4-methylenedioxyamphetamine
Dopamine
Stereotyped Behavior
3,4-Methylenedioxyamphetamine
Nucleus Accumbens
Dopamine Agents
Gas Chromatography-Mass Spectrometry
Dopamine Uptake Inhibitors
Street Drugs
Designer Drugs
Cocaine
Dopamine Plasma Membrane Transport Proteins
Rats, Sprague-Dawley
Corpus Striatum
Hallucinogens
Enzyme Multiplied Immunoassay Technique
Methylphenidate
Dose-Response Relationship, Drug
p-Chloroamphetamine
Adrenergic Uptake Inhibitors
Neostriatum
Microdialysis
Phenmetrazine
Dopamine Antagonists
Nomifensine
Pyrazolones
Receptors, Dopamine D2
Ephedrine
Fenfluramine
Psychoses, Substance-Induced
Benzphetamine
Conditioning, Operant
Substance Withdrawal Syndrome
Reward
Caudate Nucleus
Hyperkinesis
Ventral Tegmental Area
alpha-Methyltyrosine
Serotonin Agents
Phenethylamines
Apomorphine
Drug Interactions
Receptors, Biogenic Amine
Phenylpropanolamine
Serotonin
Raclopride
Self Administration
Adrenergic Agents
Barbiturates
Rats, Long-Evans
Reserpine
Chlorfenvinphos
Hair
Psychotropic Drugs
Fluorescence Polarization Immunoassay
Startle Reaction
Specific Gravity
Locomotion
Selegiline
Injections, Intraperitoneal
Receptors, Dopamine D1
Receptors, Dopamine
Sympathomimetics
Tyramine
Biogenic Monoamines
Exploratory Behavior
Narcolepsy
Conditioning, Classical
Stereoisomerism
Monoamine Oxidase Inhibitors
Phencyclidine
Immunoassay
Euphoria
Phentermine
Reinforcement Schedule
Catalepsy
Putamen
Narcotics
Biogenic Amines
Tranylcypromine
Haloperidol
Analysis of Variance
Yawning
Mescaline
Prenylamine
Lisuride
Norepinephrine Plasma Membrane Transport Proteins
Catha
Brain
N-oxygenation of amphetamine and methamphetamine by the human flavin-containing monooxygenase (form 3): role in bioactivation and detoxication. (1/566)
(+)- And (-)-amphetamine and methamphetamine were N-oxygenated by the cDNA expressed adult human flavin-containing monooxygenase form 3 (FMO3), their corresponding hydroxylamines. Two major polymorphic forms of human FMO3 were studied, and the results suggested preferential N-oxygenation by only one of the two enzymes. Chemically synthesized (+/-)-amphetamine hydroxylamine was also a substrate for the human FMO3 and it was converted to phenylpropanone oxime with a stereoselectivity ratio of trans/cis of 5:1. Human FMO3 also N-oxygenated methamphetamine to produce methamphetamine hydroxylamine. Methamphetamine hydroxylamine was also N-oxygenated by human FMO3, and the ultimate product observed was phenylpropanone. For amphetamine hydroxylamine, studies of the biochemical mechanism of product formation were consistent with the production of an N, N-dioxygenated intermediate that lead to phenylpropanone oxime. This was supported by the observation that alpha-deutero (+/-)-amphetamine hydroxylamine gave an inverse kinetic isotope effect on product formation in the presence of human FMO3. For methamphetamine, the data were consistent with a mechanism of human FMO3-mediated N,N-dioxygenation but the immediate product, a nitrone, rapidly hydrolyzed to phenylpropanone. The pharmacological activity of amphetamine hydroxylamine, phenylpropanone oxime, and methamphetamine hydroxylamine were examined for effects at the human dopamine, serotonin, and norepinephrine transporters. Amphetamine hydroxylamine and methamphetamine hydroxylamine were apparent substrates for the human biogenic amine transporters but phenylpropanone oxime was not. Presumably, phenylpropanone oxime or nitrone formation from amphetamine and methamphetamine, respectively, represents a detoxication process. Because of the potential toxic nature of amphetamine hydroxylamine and methamphetamine hydroxylamine metabolites and the polymorphic nature of N-oxygenation, human FMO3-mediated metabolism of amphetamine or methamphetamine may have clinical consequences. (+info)Electrophysiological examination of the effects of sustained flibanserin administration on serotonin receptors in rat brain. (2/566)
5-HT1A receptor agonists have proven to be effective antidepressant medications, however they suffer from a significant therapeutic lag before depressive symptoms abate. Flibanserin is a 5-HT1A receptor agonist and 5-HT2A receptor antagonist developed to possibly induce a more rapid onset of antidepressant action through its preferential postsynaptic 5-HT1A receptor agonism. Flibanserin antagonized the effect of microiontophoretically-applied DOI in the medial prefrontal cortex (mPFC) following 2 days of administration, indicating antagonism of postsynaptic 5-HT2A receptors. This reduction in the effect of locally-applied DOI was no longer present following 7-day flibanserin administration. Two-day flibanserin administration only marginally reduced the firing activity of dorsal raphe (DRN) 5-HT neurons. Following 7 days of administration, 5-HT neuronal firing activity had returned to normal and the somatodendritic 5-HT1A autoreceptors were desensitized. The responsiveness of postsynaptic 5-HT1A receptors located on CA3 hippocampus pyramidal neurons and mPFC neurons, examined using microiontophoretically-applied 5-HT and gepirone, was unchanged following a 7-day flibanserin treatment. As demonstrated by the ability of the 5-HT1A receptor antagonist WAY 100635 to selectively increase the firing of hippocampal neurons in 2- and 7-day treated rats, flibanserin enhanced the tonic activation of postsynaptic 5-HT1A receptors in this brain region. The results suggest that flibanserin could be a therapeutically useful compound putatively endowed with a more rapid onset of antidepressant action. (+info)Dose linearity study of selegiline pharmacokinetics after oral administration: evidence for strong drug interaction with female sex steroids. (3/566)
AIMS: The purpose of this study was to characterize the dose relationship of selegline and desmethylselegiline pharmacokinetics within the selegiline dose range from 5 to 40 mg. METHODS: Eight female subjects, of whom four were using oral contraceptives, ingested a single dose of 5 mg, 10 mg, 20 mg or 40 mg of selegiline HCl in an open four-period randomized study. Concentrations of selegiline and desmethlylselegiline in serum were measured by gas chromatography for 5 h. As it became evident that the use of oral steroids had a drastic effect on selegiline concentrations, the pharmacokinetic analyses were performed separately for oral contraceptive users and those not receiving any concomitant medication. RESULTS: The total AUC and Cmax of selegiline were 10-to 20-fold higher in those subjects taking oral steroids compared with subjects with no concomitant medication; this finding was consistent and statistically significant at all the four dose levels. The dose linearity of selegiline pharmacokinetics failed to be demonstrated in both groups. The AUC and Cmax of desmethylselegiline were only moderately higher (about 1.5-fold; P=NS at each dose level) in the subjects taking oral steroids than in those not receiving concomitant medication. The AUC values of desmethylselegiline increased in a dose linear manner in subjects with no concomitant medication, but not in the oral steroid group. The metabolic ratio (AUC(desmethylselegiline)/AUC(selegiline)) was several-fold lower in the group receiving oral steroids compared with the no-concomitant-medication group (P<0.005 at all the four dose levels). CONCLUSIONS: Concomitant use of oral contraceptives caused a drastic (20-fold) increase in the oral bioavailability of selegiline. The highly significant difference in the metabolic ratio between the groups provides evidence that the mechanism of the interaction between selegiline and female sex steroids involves reduced T-demethylation of selegiline. The present results suggest that concomitant use of selegiline with exogenous female sex steroids should be avoided or the dosage of selegiline should be reduced in order to minimize the risks of selegiline related adverse drug reactions. (+info)Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons. (4/566)
Amphetamineanalogs have emerged as popular recreational drugs of abuse. The number of reports of these substances producing severe acute toxicity and death is increasing. In 'Ecstasy' -associated deaths, focal necrosis in the liver and individual myocytic necrosis has been reported. Furthermore, serotonergic and dopaminergic neuronal cell damage has been observed in experimental amphetamine intoxication in laboratory animals. Here we demonstrate that subchronic exposure to D-amphetamine, methamphetamine, methylenedioxyamphetamine, and methylenedioxymethamphetamine ('Ecstasy') results in significant neurotoxicity in rat neocortical neurons in vitro. This neuronal cell death is accompanied by endonucleosomal DNA cleavage and differential expression of anti- and proapoptotic bcl-xL/S splice variants. In addition, we observed pronounced induction of cell stress-associated transcription factor c-jun and translation initiation inhibitor p97 after amphetamine treatment. These data support that the neurotoxic effects of different amphetamines are extended to rat neocortical neurons and that apoptotic pathways are involved in amphetamine-induced neurotoxicity. (+info)Amphetamine and fenproporex levels following multidose administration of fenproporex. (5/566)
Drugs that are metabolized to amphetamine or methamphetamine are potentially of significant concern in the interpretation of positive drug-testing results for amphetamines. A number of different drugs have been reported to produce amphetamine in the urine of users. One of these compounds, fenproporex, has been shown to be metabolized to amphetamine, and previous reports indicated the parent compound could be detected at low levels for up to 48 h. Administration of fenproporex for seven days (one 10-mg dose per day) to five healthy volunteers resulted in amphetamine being detected in the urine of all subjects. Peak concentrations of amphetamine ranged from approximately 2850 to 4150 ng/mL. Amphetamine could be detected (> or = 5 ng/mL) in the urine for up to nearly 170 h after the last dose. Analysis of the metabolically produced amphetamine showed the presence of both enantiomers, which can be helpful in the differentiation of some illicit amphetamine use from the use of this precursor drug. In addition, evaluation of the enantiomeric composition of the metabolite (amphetamine) can be a valuable tool in the interpretation of time since last dose. More significantly, all samples that contained amphetamine at a concentration of > or = 500 ng/mL were shown to also contain detectable amounts of the parent compound. (+info)The evolution of cerebral blood flow in the developing brain: evaluation with iodine-123 iodoamphetamine SPECT and correlation with MR imaging. (6/566)
BACKGROUND AND PURPOSE: Although it is well established that brain maturation correlates temporally with the functions the newborn or infant performs at various stages of development, the precise relationship between function and anatomic brain maturation remains unclear. The purpose of this study was to investigate the developmental changes of regional cerebral blood flow (rCBF) in infants and children using iodine-123 iodoamphetamine (123I-IMP) and single-photon emission computed tomography (SPECT). These findings were correlated with the MR imaging appearance of the brain and with known developmental changes. METHODS: Twenty-one 123I-IMP SPECT examinations of 17 patients, ranging in age from neonates to 2 years, were reviewed retrospectively. All children had had transient neurologic events in the neonatal period that did not significantly affect subsequent neuropsychological development. MR studies were performed in 12 of these patients and the MR findings were correlated with the SPECT results. RESULTS: SPECT studies showed a consistent pattern of evolving changes in 123I-IMP uptake, most likely reflecting evolution of rCBF. From the 34th postconceptional week until the end of the second month after term delivery, there was predominant uptake in the thalami, brain stem, and paleocerebellum, with relatively less cortical activity. Radionuclide uptake in both the perirolandic and occipital cortices was well seen around the 40th postconceptional week and increased rapidly thereafter, with a predominance of parietal activity. By 3 months, radionuclide uptake in the cerebellar hemispheres and parietofrontal cortices increased. Frontal and temporal activity increased by age 6 to 8 months. Uptake in the basal ganglia increased by 8 months. By the beginning of the second year, rCBF showed a similar topographic pattern to that in adults. CONCLUSION: The time course of the changes in 123I-IMP uptake in the developing brain as detected by SPECT is similar to that of myelination and most likely reflects an overall topologic maturational pattern of the brain. (+info)Direct agonists for serotonin receptors enhance locomotor function in rats that received neural transplants after neonatal spinal transection. (7/566)
We analyzed whether acute treatment with serotonergic agonists would improve motor function in rats with transected spinal cords (spinal rats) and in rats that received transplants of fetal spinal cord into the transection site (transplant rats). Neonates received midthoracic spinal transections within 48 hr of birth; transplant rats received fetal (embryonic day 14) spinal cord grafts at the time of transection. At 3 weeks, rats began 1-2 months of training in treadmill locomotion. Rats in the transplant group developed better weight-supported stepping than spinal rats. Systemic administration of two directly acting agonists for serotonergic 5-HT(2) receptor subtypes, quipazine and (+/-)-1-[2, 5]-dimethoxy-4-iodophenyl-2-aminopropane), further increased weight-supported stepping in transplant rats. The improvement was dose-dependent and greatest in rats with poor to moderate baseline weight support. In contrast, indirectly acting serotonergic agonists, which block reuptake of 5-HT (sertraline) or release 5-HT and block its reuptake (D-fenfluramine), failed to enhance motor function. Neither direct nor indirect agonists significantly improved locomotion in spinal rats as a group, despite equivalent upregulation of 5-HT(2) receptors in the lumbar ventral horn of lesioned rats with and without transplants. The distribution of immunoreactive serotonergic fibers within and caudal to the transplant did not appear to correspond to restoration of motor function. Our results confirm our previous demonstration that transplants improve motor performance in spinal rats. Additional stimulation with agonists at subtypes of 5-HT receptors produces a beneficial interaction with transplants that further improves motor competence. (+info)Evidence for a role for central 5-HT2B as well as 5-HT2A receptors in cardiovascular regulation in anaesthetized rats. (8/566)
1. The effects of injections i.c.v. of quipazine, (2 micromol kg-1) and 1-(2,5-di-methoxy-4-iodophenyl)-2-aminopropane (DOI; 2 micromol kg-1) on renal sympathetic and phrenic nerve activity, mean arterial blood pressure (MAP) and heart rate were investigated in alpha-chloralose anaesthetized rats pretreated with a peripherally acting 5-HT2 receptor antagonist. 2. Quipazine or DOI caused a rise in MAP which was associated with a tachycardia and renal sympathoinhibition in rats pretreated (i.c.v.) with the antagonist vehicle 10% PEG. These effects of quipazine were completely blocked by pretreatment with cinanserin (a 5-HT2 receptor antagonist) and attenuated by spiperone (a 5-HT2A receptor antagonist). However, pretreatment with SB200646A (a 5-HT2B/2C receptor antagonist) only blocked the sympathoinhibition, while pretreatment with SB204741 (a 5-HT2B receptor antagonist) reversed the sympathoinhibition to excitation as it also did for DOI. Quipazine also caused renal sympathoexcitation in the presence (i.v.) of a vasopressin V1 receptor antagonist. 3. Injection (i.v.) of the V1 receptor antagonist at the peak pressor response evoked by quipazine alone and in the presence of SB204741 caused an immediate fall in MAP. For quipazine alone the renal sympathoinhibition was slowly reversed to an excitation, while the renal sympathoexcitation observed in the presence of SB204741 was potentiated. In both, the quipazine-evoked tachycardia was unaffected. 4. The data indicate that cardiovascular responses caused by i.c.v. quipazine and DOI are primarily due to activation of central 5-HT2A receptors, which causes the release of vasopressin and a tachycardia. This released vasopressin appears to suppress a 5-HT2A receptor-evoked central increase in sympathetic outflow, which involves the activation of central 5-HT2B receptors indirectly by the released vasopressin. (+info)The following are some common amphetamine-related disorders:
1. Amphetamine Use Disorder (AUD): This is a chronic condition characterized by the excessive and compulsive use of amphetamines, despite negative consequences. Individuals with AUD may experience withdrawal symptoms when they stop using the drug, and may continue to use to avoid these symptoms or to achieve a "high."
2. Stimulant Psychosis: This is a condition in which an individual experiences hallucinations, delusions, or disorganized thinking due to the use of amphetamines. It is often seen in individuals who have a history of substance abuse and/or mental health issues.
3. Amphetamine-Induced Psychotic Disorder: This condition is similar to stimulant psychosis, but it is specifically caused by the use of amphetamines. It can include hallucinations, delusions, and disorganized thinking.
4. Cognitive Impairment: Long-term use of amphetamines can lead to cognitive impairments, such as memory loss, difficulty with attention, and decreased problem-solving skills.
5. Sleep Disturbances: Amphetamine use can disrupt sleep patterns, leading to insomnia or other sleep disorders.
6. Malnutrition: Individuals who use amphetamines may neglect their nutritional intake, leading to malnutrition and related health problems.
7. Cardiovascular Problems: Amphetamine use can increase heart rate and blood pressure, which can lead to cardiovascular problems such as heart attack, stroke, and arrhythmias.
8. Dental Problems: The dry mouth caused by amphetamine use can lead to tooth decay and other dental problems.
9. Infectious Diseases: Sharing needles or engaging in other risky behaviors to obtain amphetamines can increase the risk of contracting infectious diseases such as HIV/AIDS and hepatitis.
10. Financial and Legal Problems: The high cost of maintaining an amphetamine habit can lead to financial problems, and criminal activity to support the habit can lead to legal problems.
It is important to note that the specific risks associated with amphetamine use can vary depending on the individual, their health status, and the dose and duration of use. If you or someone you know is struggling with amphetamine addiction, it is important to seek professional help as soon as possible.
Substance-induced psychoses can be caused by a variety of drugs, including:
* Alcohol
* Benzodiazepines (such as diazepam)
* Cannabis
* Hallucinogens (such as LSD or psilocybin)
* Inhalants (such as solvents or aerosols)
* Opioids (such as heroin or prescription painkillers)
* Stimulants (such as cocaine or amphetamines)
Substance-induced psychoses can also be caused by certain medical conditions, such as brain injury or infection.
Symptoms of substance-induced psychosis can vary depending on the drug or substance used, but may include:
* Hallucinations (hearing, seeing, or feeling things that are not there)
* Delusions (false beliefs that are not based in reality)
* Disorganized thinking and speech
* Disorganized or catatonic behavior
* Changes in mood, such as depression or anxiety
Substance-induced psychosis can be diagnosed by a mental health professional, based on a combination of the following:
* A thorough medical history and physical examination
* Laboratory tests to rule out other causes of the symptoms
* A mental status examination to assess cognitive function and thought content
* Imaging studies (such as CT or MRI scans) to rule out other causes of the symptoms
Treatment for substance-induced psychosis typically involves stopping the use of the drugs or substances that are causing the symptoms. In some cases, medications such as antipsychotics or antidepressants may be prescribed to help manage symptoms. Behavioral therapy and support groups can also be helpful in addressing the underlying issues that led to the development of the psychosis.
Preventing substance-induced psychosis is often challenging, as it can be difficult to predict which individuals are at risk of developing psychotic symptoms. However, some strategies for prevention include:
* Avoiding the use of drugs or substances that have been linked to psychosis
* Seeking professional help if symptoms of psychosis develop
* Getting support from friends and family
* Participating in therapy and support groups to address underlying issues
It is important to note that substance-induced psychosis can be a serious condition, and seeking medical attention as soon as possible is essential. With appropriate treatment, many individuals are able to recover from the symptoms of psychosis and go on to lead fulfilling lives.
* Anxiety
* Depression
* Fatigue
* Insomnia
* Muscle and bone pain
* Nausea and vomiting
* Seizures (in severe cases)
* Sweating
* Tremors
The specific symptoms of substance withdrawal syndrome can vary depending on the substance being withdrawn from, but some common symptoms include:
* Alcohol: tremors, anxiety, insomnia, nausea and vomiting, headaches, and seizures
* Opioids: withdrawal symptoms can include anxiety, muscle aches, sweating, nausea and vomiting, diarrhea, and depression
* Benzodiazepines: withdrawal symptoms can include anxiety, insomnia, tremors, and seizures
The diagnosis of substance withdrawal syndrome is typically made based on the patient's history of substance use and the presence of withdrawal symptoms. A healthcare provider may also order laboratory tests to rule out other conditions that may be causing the symptoms. Treatment for substance withdrawal syndrome usually involves supportive care, such as rest, hydration, and pain management, as well as medication to manage withdrawal symptoms. In some cases, medical professionals may also recommend a gradual tapering of the substance over a period of time to minimize withdrawal symptoms.
It is important for individuals who are experiencing withdrawal symptoms to seek medical attention as soon as possible, as untreated withdrawal can lead to serious complications, such as seizures and dehydration. With appropriate treatment, most individuals with substance withdrawal syndrome can recover fully and successfully overcome their addiction.
Hyperkinesis can manifest in different ways, including:
1. Excessive movement or restlessness: This can include fidgeting, pacing, or other forms of constant motion.
2. Involuntary movements: These can include tremors, tics, or other sudden, uncontrolled movements.
3. Overactive behavior: This can include rapid speaking, excessive talking, or other behaviors that are not typical for the individual.
4. Difficulty sitting still or remaining quiet: This can be due to an inability to focus or a sense of inner restlessness or agitation.
5. Increased energy levels: This can result in excessive physical activity, such as running, jumping, or other forms of high-energy behavior.
Hyperkinesis can have a significant impact on daily life, making it difficult to focus, complete tasks, and maintain relationships. It is important to seek medical attention if symptoms persist or worsen over time, as hyperkinesis can be a sign of an underlying neurological or psychiatric condition that requires treatment.
Types of Substance-Related Disorders:
1. Alcohol Use Disorder (AUD): A chronic disease characterized by the excessive consumption of alcohol, leading to impaired control over drinking, social or personal problems, and increased risk of health issues.
2. Opioid Use Disorder (OUD): A chronic disease characterized by the excessive use of opioids, such as prescription painkillers or heroin, leading to withdrawal symptoms when the substance is not available.
3. Stimulant Use Disorder: A chronic disease characterized by the excessive use of stimulants, such as cocaine or amphetamines, leading to impaired control over use and increased risk of adverse effects.
4. Cannabis Use Disorder: A chronic disease characterized by the excessive use of cannabis, leading to impaired control over use and increased risk of adverse effects.
5. Hallucinogen Use Disorder: A chronic disease characterized by the excessive use of hallucinogens, such as LSD or psilocybin mushrooms, leading to impaired control over use and increased risk of adverse effects.
Causes and Risk Factors:
1. Genetics: Individuals with a family history of substance-related disorders are more likely to develop these conditions.
2. Mental health: Individuals with mental health conditions, such as depression or anxiety, may be more likely to use substances as a form of self-medication.
3. Environmental factors: Exposure to substances at an early age, peer pressure, and social environment can increase the risk of developing a substance-related disorder.
4. Brain chemistry: Substance use can alter brain chemistry, leading to dependence and addiction.
Symptoms:
1. Increased tolerance: The need to use more of the substance to achieve the desired effect.
2. Withdrawal: Experiencing symptoms such as anxiety, irritability, or nausea when the substance is not present.
3. Loss of control: Using more substance than intended or for longer than intended.
4. Neglecting responsibilities: Neglecting responsibilities at home, work, or school due to substance use.
5. Continued use despite negative consequences: Continuing to use the substance despite physical, emotional, or financial consequences.
Diagnosis:
1. Physical examination: A doctor may perform a physical examination to look for signs of substance use, such as track marks or changes in heart rate and blood pressure.
2. Laboratory tests: Blood or urine tests can confirm the presence of substances in the body.
3. Psychological evaluation: A mental health professional may conduct a psychological evaluation to assess symptoms of substance-related disorders and determine the presence of co-occurring conditions.
Treatment:
1. Detoxification: A medically-supervised detox program can help manage withdrawal symptoms and reduce the risk of complications.
2. Medications: Medications such as methadone or buprenorphine may be prescribed to manage withdrawal symptoms and reduce cravings.
3. Behavioral therapy: Cognitive-behavioral therapy (CBT) and contingency management are effective behavioral therapies for treating substance use disorders.
4. Support groups: Joining a support group such as Narcotics Anonymous can provide a sense of community and support for individuals in recovery.
5. Lifestyle changes: Making healthy lifestyle changes such as regular exercise, healthy eating, and getting enough sleep can help manage withdrawal symptoms and reduce cravings.
It's important to note that diagnosis and treatment of substance-related disorders is a complex process and should be individualized based on the specific needs and circumstances of each patient.
There are several types of narcolepsy, including:
* Type 1 narcolepsy: This is the most common form of the disorder, and it is characterized by the presence of cataplexy and low levels of hypocretin-1, a neurotransmitter that helps regulate sleep and wakefulness.
* Type 2 narcolepsy: This form of narcolepsy is similar to type 1, but it does not involve cataplexy. Instead, people with type 2 narcolepsy may experience other symptoms such as memory loss, anxiety, and depression.
* Narcolepsy with cataplexy: This is a subtype of type 1 narcolepsy that is characterized by the presence of both cataplexy and low levels of hypocretin-1.
* Narcolepsy without cataplexy: This is a subtype of type 2 narcolepsy that is characterized by the absence of cataplexy and low levels of hypocretin-1.
There is no cure for narcolepsy, but medications such as stimulants, modafinil, and sodium oxybate can help manage symptoms. Behavioral interventions such as scheduled napping and exercise can also be helpful in managing the disorder.
It is important to note that catalepsy is not the same as catatonia, which is a more specific condition characterized by a wide range of symptoms, including immobility, mutism, negativism, and emotional dysregulation. However, catalepsy and catatonia do share some similarities, and the terms are often used interchangeably in clinical practice.
The exact cause of catalepsy is not fully understood, but it is thought to be related to dysfunction in certain areas of the brain, such as the neocortex and basal ganglia. In some cases, catalepsy may be a side effect of medication or drug intoxication.
Treatment for catalepsy typically focuses on addressing the underlying cause, such as managing seizures or withdrawing from drugs. In some cases, medications such as benzodiazepines or antipsychotics may be used to help manage symptoms. Other approaches, such as physical therapy and behavioral interventions, may also be helpful in improving mobility and function.
1. Cocaine dependence: This is a condition in which an individual becomes psychologically and physiologically dependent on cocaine, and experiences withdrawal symptoms when they stop using the drug.
2. Cocaine intoxication: This is a state of altered consciousness that can occur when an individual takes too much cocaine, and can cause symptoms such as agitation, confusion, and hallucinations.
3. Cocaine-induced psychosis: This is a condition in which an individual experiences a break from reality, characterized by delusions, hallucinations, and disorganized thinking.
4. Cocaine-associated cardiovascular problems: Cocaine use can increase heart rate and blood pressure, and can cause damage to the heart and blood vessels.
5. Cocaine-associated respiratory problems: Cocaine use can constrict the airways and make breathing more difficult, which can lead to respiratory failure.
6. Cocaine-associated neurological problems: Cocaine use can cause nerve damage and seizures, particularly in individuals who use the drug frequently or in large quantities.
7. Cocaine withdrawal syndrome: This is a set of symptoms that can occur when an individual stops using cocaine, including depression, anxiety, and fatigue.
8. Cocaine-related anxiety disorders: Cocaine use can exacerbate anxiety disorders such as generalized anxiety disorder, panic disorder, and social anxiety disorder.
9. Cocaine-related mood disorders: Cocaine use can also exacerbate mood disorders such as depression and bipolar disorder.
10. Cocaine-related cognitive impairment: Chronic cocaine use can impair cognitive function, particularly in areas such as attention, memory, and decision-making.
It is important to note that the effects of cocaine can vary depending on the individual, the dose and frequency of use, and other factors such as the method of administration and any underlying medical conditions. If you or someone you know is struggling with cocaine addiction, it is important to seek professional help as soon as possible.
Bread and Amphetamines
Amphetamine
Amphetamine (disambiguation)
Substituted amphetamine
Amphetamine (film)
Amphetamine dependence
History and culture of substituted amphetamines
Amphetamine Reptile Records
Amphetamine type stimulant
Amphetamine Reptile Records discography
Cocaine and amphetamine regulated transcript
2,5-Dimethoxy-4-(2-fluoroethyl)amphetamine
Organised crime in Australia
Methylone
Dextroamphetamine
Methamphetamine
2,5-Dimethoxy-4-iodoamphetamine
Adderall
Cocaine
Prenatal cocaine exposure
Profetamine
List of psychoactive drugs used by militaries
Effects of cannabis
Phenethylamine
2-Fluoroamphetamine
Psychedelic drug
Royal Commission into Drug Trafficking
Van Dyke Parks
4-Fluoroamphetamine
Oussama Mellouli
Amphetamine, 3'-fluoro-4'-methoxy
Shroomery - Amphetamines use Statistics in real-time - DopeStats
Truth about Amphetamines, LSD, Ecstasy - free book - Ch 7
Substance use - amphetamines: MedlinePlus Medical Encyclopedia
Amphetamine Use Soars in Locked Down Finland: Study | Courthouse News Service
Erowid.org: Erowid Reference 1149 : Problems in Identification of Methylenediony and Methoxy Amphetamines : Sreenivasan VR
Browsing by Subject "Amphetamine"
Amphetamine poisoning
Notes from the Field: Amphetamine Use Among Workers with Severe Hyperthermia - Eight States, 2010-2019 | MMWR
Amphetamine Archives - ChrisWrites.com
Alcohol and other drug treatment services in Australia annual report, Amphetamines - Australian Institute of Health and Welfare
Erowid.org: Erowid Reference 697 : The effects of (+/-)-methylenedioxymethamphetamine and (+/-)-methylenedioxyamphetamine in...
ways to Pass amphetamines Drug Test, beat amphetamines drug testing / screening
Young People on Amphetamines for ADHD Have Twice the Psychosis Risk Compared to Other Stimulants | McLean Hospital
Chronicle Book Review: 'On Speed: The Many Lives of Amphetamine,' by Nicolas Rasmussen (2008, New York University Press, 352 pp...
Analysis of Amphetamine and Methamphetamine in Whole Blood by Solid Phase Extraction and Gas Chromatography - Mass Spectrometry...
Alprazolam, amphetamine, ultram, diazepam online: +1(775)773-5306 - Veterans ...
Plus it
What is Amphetamine? | Methamphetamine Drug Testing | Psychemedics
Rapid GC-MS confirmation of amphetamines in urine by extractive acylation
16.1: Amphetamines and the Brain - Chemistry LibreTexts
Safe Buy Amphetamine Special Internet Prices (up to 40% off average US price) >> www...
WHO EMRO | Use of amphetamine-type stimulants in the Islamic Republic of Iran, 2004-2015: a review | Volume 23, issue 3 | EMHJ...
The Definitive Guide to AMPHETAMINES
Amphetamine Street Names
Myron Elkins - Factories Farms & Amphetamines (Mod) | hollowbonerecords
Tarina Tarantino
Explore Amphetamine | PiHKAL · info
Blog \ Amphetamine Evaluation 2021
Methamphetamine5
- three postmortem blood assays detected methamphetamine, and four qualitative screening tests detected amphetamine or amphetamine analogs in workers without amphetamine prescriptions. (cdc.gov)
- Amphetamine and methamphetamine are two well-known phenylethylamines. (erowid.org)
- AODTS NMDS data for amphetamines correspond to the Australian Standard Classification of Drugs of Concern (ASCDC) for the general 'amphetamines' classification, in which methamphetamine is a sub-classification (ABS 2011). (aihw.gov.au)
- Data on different forms of amphetamines-methamphetamine specifically-have not been separately reported over time due to the nature of the classification structure used in this collection. (aihw.gov.au)
- Amphetamine-type stimulants (ATS) such as "ecstasy" and methamphetamine now rank as Africa's second most widely abused drug type. (who.int)
Stimulants7
- Amphetamines are central nervous system stimulants that can induce hyperthermia independently or in combination with other risk factors ( 2 ). (cdc.gov)
- ABSTRACT Amphetamine-type stimulants (ATS) are the second most commonly used illicit drugs in the world, after cannabis. (who.int)
- La présente étude a pour objectif d'évaluer la situation de la consommation de stimulants de type amphétamines en République islamique d'Iran. (who.int)
- Les résultats indiquent que la consommation auto-déclarée de methamphétamine et d'ectasie en 2016 était inférieure à 1 % dans la population générale et parmi les étudiants en universités et les élèves du secondaire, mais que la prévalence des stimulants de type amphétamines était plus élevée parmi certains groupes. (who.int)
- Multi-analyte confirmations for amphetamine type stimulants are therefore required, but traditional gas chromatography-mass spectrometry methods necessitate lengthy analytical procedures with prolonged sample turn-around times. (up.ac.za)
- Amphetamine belongs to the group of stimulants and is classified as a phenethylamine. (saferparty.ch)
- Amphetamine-type stimulants : a global view. (who.int)
Illicit2
- Amphetamine - Illicit amphetamine appears as crystals, chunks, and fine to coarse powders, off-white to yellow in color, and supplied loose (in plastic or foil bags) or in capsules or tablets of various sizes and colors. (psychemedics.com)
- Recommended methods for testing illicit ring-substituted amphetamine derivatives : manual for use by national narcotics laboratories. (who.int)
Addictive2
- Amphetamines are widely abused, addictive drugs. (globalchange.com)
- Both of those amphetamines and methamphetamines are addictive. (bookmarkja.com)
Cocaine3
- In addition, very small amounts of ketamine, cocaine, MDMA and phenylacetone were analysed in 5.5 % of the amphetamine samples in 2021. (saferparty.ch)
- The Role of Cocaine- and Amphetamine-Regulated Transcript (CART) in Cancer: A Systematic Review. (bvsalud.org)
- The functions of cocaine - and amphetamine -regulated transcript (CART) neuropeptide encoded by the CARTPT gene vary from modifying behavior and pain sensitivity to being an antioxidant . (bvsalud.org)
2020-211
- In 2020-21, amphetamines were reported as a drug of concern (either principal or additional) in 3 in 10 treatment episodes (31% or 69,600 episodes) (Table Drg.4). (aihw.gov.au)
Derivatives3
- Amphetamine and related derivatives are widely abused central- and psychostimulants. (up.ac.za)
- The proposed assay is precise and accurate for confirmation of amphetamine and derivatives in urine. (up.ac.za)
- Analogs or derivatives of AMPHETAMINE. (bvsalud.org)
Substance1
- Nine (26.5%) of these 34 workers tested positive for an amphetamine-class substance. (cdc.gov)
Attention deficit2
- Two cases involved legal use of prescription amphetamines to treat attention deficit hyperactivity disorder, and both persons who used legal prescription amphetamines died. (cdc.gov)
- Amphetamine is a category of drugs that stimulate the central nervous system and the brain and is often prescribed for people with narcolepsy and attention deficit hyperactivity disorder (ADHD). (trupathrecovery.com)
Overdose3
- We describe five patients with complications following amphetamine overdose. (amphetamines.com)
- Overdose) where to buy Amphetamine your health and where to buy Amphetamine your life. (bigkahunaadventures.com)
- Thus, there is a risk that users overdose when using pure amphetamine due to the more subtle and later onset effect of amphetamine. (saferparty.ch)
Substances3
- Where to buy Amphetamine substances all cause a risk (i. (bigkahunaadventures.com)
- In 2021, 72 % of the amphetamine samples submitted contained at least one pharmacologically active extender (such as also caffeine), one or more synthetic impurities or contamination (smear contamination in minigrips already used with other substances). (saferparty.ch)
- The most frequently detected unexpected psychoactive substances in amphetamine samples are still caffeine and synthesis by-products. (saferparty.ch)
Opioids1
- Opioids get the headlines, while amphetamines are mounting a stealth assault in the drugs-of-abuse landscape. (psychemedics.com)
Ecstasy2
- MDMA or Ecstasy (3-4-methylenedioxymethampheta-mine), is a synthetic drug with amphetamine-like and hallucinogenic properties. (psychemedics.com)
- Ecstasy: known as the "White Widow Drug" is a powerful synthetic form of synthetic marijuana derived from the leaves of certain African how to get Amphetamine. (bigkahunaadventures.com)
Addiction4
- Using amphetamines can lead to addiction. (medlineplus.gov)
- Addiction happens when you use amphetamines to get high or improve performance. (medlineplus.gov)
- It is also thought to promote the development of erectile dysfunction how to get Amphetamine sex addiction andor to how to get Amphetamine sexual attraction or arousal. (bigkahunaadventures.com)
- At TruPath, we can help you overcome your addiction to amphetamine drugs through a safe medical detox program, followed by inpatient residential treatment and outpatient programs like our intensive outpatient program, day programs, and continuing care. (trupathrecovery.com)
Assays1
- As with all Psychemedics drug screens, our Amphetamines assays are FDA 510k-cleared. (psychemedics.com)
Psychoactive1
- If you have received a prescription of a psychoactive drug from a where to buy Amphetamine who can not give you the required pills before you take them. (bigkahunaadventures.com)
Widely1
- Within a few more years, amphetamines were being widely prescribed for an ever-increasing array of "diseases," including obesity and neurotic depression. (stopthedrugwar.org)
Insufficient1
- Synthetic impurities result from improper production and/or insufficient purification of amphetamine in the production laboratory. (saferparty.ch)
Commonly2
- Many of the herbalists who sell Amphetamine will arrange for medical testing or treatment The two most commonly used depressants are alcohol and tobacco. (bigkahunaadventures.com)
- Caffeine was analysed in 48.5 % of amphetamine samples in 2021 and thus remains the most commonly used extender. (saferparty.ch)
Drugs5
- Amphetamines are drugs. (medlineplus.gov)
- You are taking an antihistamine, where to buy Amphetamine muscle relaxant or other drugs to relax you or get a good night's sleep. (bigkahunaadventures.com)
- Driving while intoxicated is often referred to as driving under the influence of alcohol how to get Amphetamine drugs. (bigkahunaadventures.com)
- Amphetamines are a broad category of drugs, and there are several types that vary in chemical structure. (trupathrecovery.com)
- A medical detox program is the safest way to stop using these types of drugs, even prescription Adderall or Ritalin, ensuring you have 24-hour medical care and prescription medication options to keep you safe as your body adjusts to the lack of amphetamine medications in your system. (trupathrecovery.com)
Caffeine3
- The term speed is usually understood to mean a mixture of caffeine and amphetamine. (saferparty.ch)
- It is important to mention that the effect of caffeine in amphetamine samples is desired by many users, as the pure amphetamine effect is often perceived as too subtle and too long-acting. (saferparty.ch)
- It should be noted that many amphetamine users are used to the fast-onset and strong effect of caffeine and often declare a sample mixed with caffeine to be "very strong" before analysis. (saferparty.ch)
Pills2
- In that case, a coworker later alleged to OSHA that before the shift started, the supervisor had provided pills whose appearance was consistent with those of a prescription amphetamine. (cdc.gov)
- By the late 1960s some 5 million Americans were gobbling down amphetamines under a doctor's supervision, and another 2 or 3 million were using them as "thrill pills" outside the bounds of medical practice. (stopthedrugwar.org)
Prescription6
- Amphetamines are illegal when they are used without a prescription to get high or improve performance. (medlineplus.gov)
- You usually do not get addicted to prescription amphetamines when you take them at the right dosage to treat your health condition. (medlineplus.gov)
- Cheap Pharmacy to Buy Amphetamine Without a Doctor Prescription. (bigkahunaadventures.com)
- You can order Amphetamine without a prescription, but it's important to know the risks involved before doing so. (bigkahunaadventures.com)
- Best Pharmacy to Buy Amphetamine Generic Without Prescription. (bigkahunaadventures.com)
- Amphetamine is legal to buy legally in Australia if you have a prescription from a doctor. (bigkahunaadventures.com)
Search1
- Results of search for 'su:{Amphetamines. (who.int)
Isotope1
- Lithium: a radioactive metal isotope that is a very common and very how to get Amphetamine energy molecule. (bigkahunaadventures.com)
Dopamine2
- Amphetamines also cause the brain to release dopamine. (medlineplus.gov)
- A preliminary report of an in vivo investigation of amphetamine-induced dopamine release in schizophrenia. (snmjournals.org)
Effects3
- The effects of amphetamine are discussed along with the diagnosis and treatment of patients with such poisoning. (amphetamines.com)
- Objectives To characterize the effects of amphetamine on dopaminergic neurotransmission in schizophrenia. (snmjournals.org)
- Many people find the positive effects of Amphetamine very surprising. (bigkahunaadventures.com)
Tablets1
- But by the 1940s, amphetamine tablets by the millions were being used by soldiers on all sides of World War II as energy- and morale-enhancers. (stopthedrugwar.org)
Appetite1
- Amphetamine - A psychostimulant drug that is known to produce increased wakefulness and focus in association with decreased fatigue and appetite. (psychemedics.com)
Illegal1
- Some how to get Amphetamine like Russia do not have strict laws on the safe storage or transportation of radioactive materials like lithium and are even illegal to ship it across territorial borders. (bigkahunaadventures.com)
Content1
- The amphetamine content of the samples handed in at the DIZ has been relatively constant between 50 % and 60 % since 2018. (saferparty.ch)
Severe2
- To identify additional cases of severe hyperthermia in which workers tested positive for amphetamines, and to support OSHA's enforcement activities, OOMN reviewed all medical records and investigation materials submitted by other OSHA offices to OOMN during January 1, 2010-August 31, 2019. (cdc.gov)
- Some people may experience severe withdrawal symptoms from amphetamines that include cardiac problems and chest pain, serious headaches, and seizures. (trupathrecovery.com)
Common4
- Amphetamines was the second most common principal drug of concern, recorded in almost 1 in 4 treatment episodes (24% or 54,300 episodes) (Table Drg.4). (aihw.gov.au)
- Amphetamines has remained the second most common PDOC since 2015-16, when it surpassed cannabis for the first time (Table Drg.5). (aihw.gov.au)
- Troubleshooting documentation for common issues with Amphetamine. (freshdesk.com)
- If Amphetamine is not working properly, a common solution is to reset Amphetamine's preferences. (freshdesk.com)
Legal1
- By the 1950s, Beat writers like Jack Kerouac and William Burroughs were enshrining it in a nascent counterculture, and by the 1960s, as legal amphetamine production reached record highs, speed abuse was identified as a serious problem, not only by doctors, researchers, law enforcement, and fear-mongering politicians, but also by the counterculture itself. (stopthedrugwar.org)
Analysis3
- He revealed the findings in a joint statement with the police, who said the analysis suggested amphetamine use in Helsinki had reached "record levels. (courthousenews.com)
- Psychemedics enjoys a long legacy of firsts in testing for Amphetamines using hair analysis. (psychemedics.com)
- In total, 174 samples declared as amphetamine were handed in for analysis at the Drug Information Centre (DIZ) in Zurich in 2021. (saferparty.ch)
Health2
- Finns may be known for their love of vodka and beer, but growing numbers in the Nordic nation appear to have turned to amphetamines to cope with the coronavirus lockdown, health officials said on Thursday. (courthousenews.com)
- Although researchers could not directly link the spike in drug use to the lockdown, "the fact remains that amphetamine use has been higher than ever before, at least in the Helsinki metropolitan area," said Teemu Gunnar, head of forensic toxicology at the National Institute for Health and Welfare. (courthousenews.com)
Terms1
- In some cases, Amphetamines.com could charge a small cost per call, to a licensed treatment center, a paid advertiser, this allows Amphetamines.com to offer free resources and information to those in need by calling the free hotline you agree to the terms of use . (amphetamines.com)
Energy2
- Some people take their drug of choice on a regular basis with coffee or tea, often to get a where to buy Amphetamine in energy. (bigkahunaadventures.com)
- They use Amphetamine to feel more energy and to relax in the mind. (bigkahunaadventures.com)
Street1
- There are different kinds of street amphetamines. (medlineplus.gov)
Drug3
- what is most fascinating for students of American drug policy is the way his narrative lays the blame for the creation of subsequent amphetamine abuse problems squarely at the feet of market-hungry pill makers, pill-pushing doctors, and, of course, the American military, which exposed millions of GIs to the pleasures -- and dangers -- of speed. (stopthedrugwar.org)
- Psychemedics' hair tests for Amphetamines are part of our 5-panel drug test and Adderall is offered as an add-on. (psychemedics.com)
- During mobile drug checking missions carried out in the city of Zurich in 2021, 26 amphetamine samples were handed in and analysed. (saferparty.ch)
People1
- Use of amphetamines in the country of 5.5 million people has tripled since 2013 according to wastewater studies, Gunnar said. (courthousenews.com)
Medical2
- Amphetamines can be used to treat medical conditions such as ADHD, but is also taken recreationally, sometimes under the name "speed. (courthousenews.com)
- What Rasmussen is really interested in is the interaction between the pharmaceutical industry, the medical profession, and broader social forces afoot in Western culture, and amphetamines make a fascinating, if surprising, vehicle for his meditations. (stopthedrugwar.org)
Data2
- Data available in the AODTS NMDS report the narrow group 'amphetamines' classification. (aihw.gov.au)
- With US Government reported seizures up 142% between 2017-2018 and Psychemedics data showing positivity rates for amphetamines up 36% over the past three years, conditions are right for the number of deaths to accelerate. (psychemedics.com)
Problems1
- "Problems in Identification of Methylenediony and Methoxy Amphetamines" Journal of Criminal Law, Criminology & Police Science . (erowid.org)
Cases1
- In rare cases, some or all of Amphetamine's preferences may not save as expected or are reset to their default values upon restarting Amphetamine or reb. (freshdesk.com)
High quality2
- When you purchase Amphetamine from our online store, you are getting a high quality product at a competitive price. (bigkahunaadventures.com)
- Contrary to the widespread opinion among users, pastes (liquid/moist samples that have to be dried) do not indicate a particularly high quality of amphetamine. (saferparty.ch)